HIV affects people of every age, race, gender, and orientation. An estimated 1.2 million people in the United States have HIV, including about 161,800 people who are unaware of their status. For people with undiagnosed HIV, testing is the first step in maintaining a healthy life and preventing HIV transmission. The CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once as part of routine health care. Sexually active gay and bisexual men may benefit from more frequent testing. Even if you are in a monogamous relationship (both you and your partner are having sex only with each other), you should find out for sure whether you or your partner has HIV. MedLink Georgia offers HIV testing at all MedLink locations with rapid testing at our Lawrenceville office. Contact us to schedule an appointment today.
Know the facts.
What is HIV?
HIV is a virus that attacks the immune system. If left undiagnosed or untreated, it can become life-threatening, but HIV is manageable.
How Can HIV Spread?
There are only a couple of specific ways that HIV is passed on—through blood and sexual body fluids. It is NOT spread by air, water, saliva, sweat, tears, kissing, insects, pets, toilets, food, or drinks.
Who is at Risk?
Everyone. HIV affects people of every age, race, gender, and orientation. While some are more at risk than others, we all fall somewhere in the stats
What is PreP?
PrEP is a method for people who are HIV negative to prevent and reduce the risk of HIV infection by taking one pill a day. Studies have shown that PrEP is highly effective for preventing HIV when used as prescribed.
Who Should Use PreP? PrEP was created for those who may be at risk for contracting HIV from sex. Consult with your provider about PrEP if you:
Have an HIV positive partner
Have an at-risk HIV partner
Have had anal or vaginal sex without condoms
Have had sex partners in the past six months that do not know their HIV status
Have a partner that has sex partners who do not use condoms regularly
Have a partner that has been diagnosed with another STD in the past six months
MedLink Georgia, Inc. is a non-profit 501 (C) (3) corporation, established as the Oconee- Oglethorpe Primary Health Care Center in 1979 under the Rural Health Initiative Program. The corporation is governed by a Board of Directors with representation from each county where the centers are located.
MedLink Georgia serves patients from 26 Northeast Georgia counties and contiguous North and South Carolina communities.
If you speak a language other than English and need assistance, language assistance services, free of charge, are available to you. Call any MedLink Georgia center for information.
Download MedLink Georgia App
MedLink Georgia is a Health Center Program grantee under 42 U. S. C. 254b, and a deemed Public Health Service employee site under 42 U. S. C. 233 (g) – (n)
MedLink Georgia is Covered under the Federal Tort Claims Act.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number H80CS00427, Health Center Program, for $6,777,945 with 61.7% from nongovernmental sources. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
MedLink Georgia, Inc. complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability or sex. If you speak a language other than English and need assistance, language assistance services, free of charge, are available to you at all MedLink Community Health Centers.
MedLink Georgia cumple con las leyes de derechos civiles federales y no discrimina por raza, color, origen, nacional, edad, discapacidad, o genero. Si usted habla un idioma aparte de ingles y necesita ayuda, servicios de lenguage gratuitos estan disponible para usted. Llame a cualquier centro de MedLink Georgia para mas informacion.
COVID-19 nasopharyngeal or oropharyngeal test is $80